Literature DB >> 9515043

Ischemic preconditioning: effects on pH, Na and Ca in newborn rabbit hearts during Ischemia/Reperfusion.

H Liu1, P M Cala, S E Anderson.   

Abstract

In adult hearts, ischemic preconditioning (PC) has been shown to decrease ischemia-induced changes in intracellular pH (pHi) and [Ca] ([Ca]i) and decrease associated injury. These results are consistent with the interpretation that PC decreases the stimulus for Na uptake via Na/H exchange, thereby decreasing intracellular Na (Nai) accumulation, and thus decreasing the change in force driving Na/Ca exchange, which otherwise contributes to ischemia-induced increases in [Ca]i. Given documented age-related differences in myocardial responses to ischemia, we tested the hypothesis that in newborn hearts, PC will diminish intracellular [H], Nai, and [Ca]i during ischemia/reperfusion. NMR was used to measure pHi, Nai, [Ca]i, ATP, and PCr in isolated newborn (4-7 days) rabbit hearts Langendorff-perfused with Krebs-Henseleit solution equilibrated with 95% O2/5% CO2 at 36+/-1 degrees C. Control hearts were perfused 30 min before initiating 40 min global ischemia followed by 40 min reperfusion. PC hearts were treated the same except four 5-min intervals of ischemia each followed by 10 min of perfusion which preceded global ischemia. At end ischemia, pHi was higher in PC than control hearts (6.31+/-0.03 v 5.83+/-0.05; P<0.05). Similarly, PC diminished Nai-accumulation during ischemia and reperfusion (P<0.05). Control Nai rose from 16.2+/-2.6 to 108.8+/-10.3 (mEq/kg dry weight) and recovered to 55.2+/-10.1 and the corresponding values for PC hearts were 25.6+/-6.2, 70.0+/-7.9 and 21.9+/-5.2. PC also improved [Ca]i recovery during reperfusion (P<0.05). Control [Ca]i rose from 418+/-43 to 1100+/-78 (nm/l) and recovered to 773+/-63, whereas in PC hearts the values were 382+/-40, 852+/-136 and 371+/-45, respectively. In addition, PC decreased coronary resistance during reperfusion (P<0.05) as reflected by lower perfusion pressures under constant flow conditions (65.9+/-1.5 v 56. 1+/-4.1 mmHg at end of reperfusion). Finally, PC improved recovery of left-ventricular developed pressure (LVDP-43.8+/-12.0 v 17.2+/-3. 0% of control; P<0.05) and diminished CK release (607+/-245 v 2432+/-639 IU/g dry weight; P<0.05) during reperfusion. The results are consistent with the hypothesis. Copyright 1998 Academic Press Limited

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515043     DOI: 10.1006/jmcc.1997.0636

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  KATP channel blocker does not abolish the protective effect of Na+/H+ exchange 1 inhibition against ischaemia/reperfusion in aged myocardium.

Authors:  Hong Liu; Peter G Moore
Journal:  Eur J Anaesthesiol       Date:  2010-08       Impact factor: 4.330

2.  Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion.

Authors:  Lingyun Zu; Xiaoxu Zheng; Bing Wang; Nirmal Parajuli; Charles Steenbergen; Lewis C Becker; Zheqing P Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

3.  Inhibition of the Na+/H+ exchanger protects the immature rabbit myocardium from ischemia and reperfusion injury.

Authors:  R-H Zhou; C Long; J Liu; B Liu
Journal:  Pediatr Cardiol       Date:  2007-09-15       Impact factor: 1.655

4.  Na/H exchange inhibition protects newborn heart from ischemia/reperfusion injury by limiting Na+-dependent Ca2+ overload.

Authors:  Hong Liu; Peter M Cala; Steve E Anderson
Journal:  J Cardiovasc Pharmacol       Date:  2010-03       Impact factor: 3.105

5.  Ischemic injury of the developing heart.

Authors:  Bohuslav Ost'ádal; Ivana Ost'ádalová; L Skárka; F Kolár; Jan Kopecký
Journal:  Exp Clin Cardiol       Date:  2002

Review 6.  The mitochondrial death pathway: a promising therapeutic target in diseases.

Authors:  Sanjeev Gupta; George E N Kass; Eva Szegezdi; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.